Real-Time, Real-World Impact: How a Radiation Oncology Quality Collaborative, MROQC, Is Shaping the Future of Radiation Oncology

The Michigan Radiation Oncology Quality Consortium (MROQC) is a Blue Cross Blue Shield of Michigan-Blue Care Network (BCBSM-BCN) sponsored Collaborative Quality Initiative (CQI). It comprises 25 Radiation Oncology academic and community practice facilities across Michigan, working together to identify best practices and guide the appropriate use of high-cost technology in radiation treatment. Since its inception in 2011, MROQC has collected real-world, real-time prospective data for nearly 40,000 patients spanning breast, lung, prostate cancers, and bone metastases. Unlike clinical trial data, which can take years to implement, real-world data provides immediate, actionable insights. This session will demonstrate how MROQC integrates patient-reported (PROs) and physician-reported outcomes to bridge the gap between research and clinical practice. It will also explore how payer-provider collaborations support a sustainable framework for quality improvement. Attendees will leave with practical strategies to enhance patient care using real-world data, along with insights on overcoming barriers to implementing quality metrics and achieving equity across diverse populations.

Topics:

  1. BCBSM's Perspective on Quality Improvement and Value-Based Care
    Lori Pierce, MD, FASTRO and Thomas Leyden, MBA
  2. Highlighting Operational Aspects of MROQC: Data Collection and Implementation of Improvements
    Melissa Mietzel, MS and David Heimburger, MD
  3. Leveraging Registry Data for Treatment Optimization: A Physicist's Perspective
    Martha Matuszak, PhD
  4. Clinical Applications of MROQC Data: Reducing Patient Side Effects in Radiation Oncology
    Frank Vicini, MD, FASTRO
  5. Q&A
    Shruti Jolly, MD, MBA

This activity is available from November 26, 2025 through 11:59 p.m. Eastern time on November 25, 2027. This activity does not offer continuing medical education credit.

This activity was originally presented and recorded at the 2025 ASTRO Annual Meeting.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify key strategies for developing and sustaining successful collaborative quality improvement programs.
  • Evaluate the role of real-world data in reducing treatment-related toxicities and hospitalizations.
  • Apply evidence-based practices to enhance patient safety, improve quality of care, and ensure equitable access to radiation therapy.
Course summary
Available credit: 
  • 1.25 Certificate of Attendance
    This activity was designated for 0.00 AMA PRA Category 1 Credit™.
Course opens: 
11/26/2025
Course expires: 
11/25/2027
Cost:
$0.00
Rating: 
0

This activity does not offer continuing medical education credit.

Available Credit

  • 1.25 Certificate of Attendance
    This activity was designated for 0.00 AMA PRA Category 1 Credit™.

Price

Cost:
$0.00
Please login or register to take this course.

Course Fees:
This course is provided at no fee.

Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date.

Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.

The activity and its materials will only be available on the ASTRO website until November 25, 2027, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.